Skip to the page

Data / Form D filings / Arpeggio Biosciences, Inc.

Arpeggio Biosciences, Inc.: Form D filings

Arpeggio Biosciences, Inc., a technology company in Boulder, CO, filed 5 Form D notices with the SEC between 2019 and 2025. The latest, on November 24, 2025, reports $20 million sold of a $35.3 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4888 Pearl East Circle, Suite 110E, Boulder, CO, 80301
Phone
(402) 525-6851
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1786698

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 24, 2025New notice$35,318,765$20,037,075$15,281,69012Nov 12, 2025sec.gov
Mar 27, 2025New notice$4,593,397$4,026,774$566,62314Mar 19, 2025sec.gov
Sep 23, 2022New notice$20,279,156$20,248,534$30,62228Aug 3, 2022sec.gov
Sep 6, 2019New notice$3,000,000$1,970,000$1,030,0005Aug 22, 2019sec.gov
Aug 29, 2019New notice$500,000$125,000$375,0001Aug 16, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Timothy G. ReadExecutive Officer
Laura G. NorrisExecutive Officer
David G. AllisonDirector
Joseph G. AzofeifaExecutive Officer, Director
Mira G. ChaurushiyaDirector
Samuel G. KintzDirector
Aaron G. RoystonDirector

Other technology companies in Colorado that filed recently

Every Form D from the week of Nov 24, 2025 · All recent filings in Colorado · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Arpeggio Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.